Skip to content
healthcare.dev

Atovaquone

NDC 0121-1016, Atovaquone, suspension, from PAI Holdings, LLC dba PAI Pharma.

Product NDC
0121-1016
Status
Listed
Labeler
PAI Holdings, LLC dba PAI Pharma
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214272
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0121-1016 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATOVAQUONE750 mg/5mL

Pharmacologic classes

Antimalarial [EPC]; Antiprotozoal [EPC]

Package NDCNDC-11Package
0121-1016-18001211016183 TRAY in 1 CASE (0121-1016-18) / 6 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-1016-05)
0121-1016-42001211016427 TRAY in 1 CASE (0121-1016-42) / 6 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-1016-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels?ndc=0121-1016
  • NADAC price for package 00121101642

    GET /v1/drugs/nadac/00121101642

Use it

Look up 0121-1016 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0121-1016 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0121-1016. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.